[{"Assets_0_Q1_USD":7261000000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":281000000.0,"NetIncomeLossConverted_1_Q1_USD":173000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":148000000.0,"StockholdersEquityConverted_0_Q1_USD":4635000000.0,"EarningsPerShareBasic_1_Q1_USD":1.18,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":147000000.0,"EarningsPerShareDiluted_1_Q1_USD":1.17,"RevenuesConverted_1_Q1_USD":859000000.0,"Ticker":"ILMN","CIK":"1110803","name":"ILLUMINA, INC.","OfficialName":"Illumina Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"53766364980.0","Country":"United States","Sector":"Health Care","Industry":"Medical Specialities","Market":"NASDAQ","SP500":"SP500","filed":"20200501"}]